We are live on
!
Find out more
SIM
Sentry Investment Management Portfolio holdings
AUM
$146M
1-Year Est. Return
23.67%
This Fund
S&P 500
This Quarter
Est. Return
+8.89%
1 Year Est. Return
+23.67%
3 Year Est. Return
+94.52%
5 Year Est. Return
+132.31%
10 Year Est. Return
+450.55%
AUM
$1.85B
AUM Growth
+$161M
(+9.5%)
Cap. Flow
+$20.7M
Cap. Flow
% of AUM
1.12%
Top 10 Holdings %
Top 10 Hldgs %
44.31%
Holding
545
New
19
Increased
207
Reduced
207
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$8.76M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.1M |
| 3 |
Amazon
AMZN
|
+$5.58M |
| 4 |
Procter & Gamble
PG
|
+$5.43M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$4.53M |
| 2 |
Olin
OLN
|
+$4.38M |
| 3 |
Merck
MRK
|
+$4.09M |
| 4 |
B
Barrick Mining
B
|
+$3.9M |
| 5 |
GE Aerospace
GE
|
+$3.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.09% |
| 2 | Healthcare | 8.16% |
| 3 | Technology | 7.64% |
| 4 | Industrials | 6.46% |
| 5 | Energy | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Franco-Nevada
FNV
$46B
| – | – |
-39,900
| Closed | -$1.81M |
|
527
VanEck Gold Miners ETF
GDX
$27.4B
| – | – |
-49,000
| Closed | -$1.23M |
|
|
B
528
Barrick Mining
B
$73.2B
| – | – |
-209,300
| Closed | -$3.9M |
|
529
GSK
GSK
$106B
| – | – |
-14,320
| Closed | -$898K |
|
530
IAMGOLD
IAG
$10.5B
| – | – |
-251,300
| Closed | -$1.19M |
|
531
Kinross Gold
KGC
$32.8B
| – | – |
-398,800
| Closed | -$2.01M |
|
532
Murphy USA
MUSA
$9.61B
| – | – |
-1,850
| Closed | -$75K |
|
|
NVO
533
Novo Nordisk
NVO
$209B
| – | – |
-49,000
| Closed | -$829K |
|
534
Novartis
NVS
$297B
| – | – |
-13,727
| Closed | -$944K |
|
|
535
Olin
OLN
$2.12B
| – | – |
-189,900
| Closed | -$4.38M |
|
536
Sanofi
SNY
$104B
| – | – |
-16,500
| Closed | -$835K |
|
537
Teva Pharmaceuticals
TEVA
$41.2B
| – | – |
-21,100
| Closed | -$797K |
|
538
Viavi Solutions
VIAV
$9.66B
| – | – |
-23,733
| Closed | -$199K |
|
|
VTLE
539
DELISTED
Vital Energy
VTLE
| – | – |
-125
| Closed | -$74K |
|
|
AUY
540
DELISTED
Yamana Gold, Inc.
AUY
| – | – |
-102,800
| Closed | -$1.07M |
|
|
ANV
541
DELISTED
Allied Nevada Gold Corp
ANV
| – | – |
-264,200
| Closed | -$1.1M |
|
|
MOLX
542
DELISTED
MOLEX INC
MOLX
| – | – |
-10,000
| Closed | -$385K |
|
|
NYX
543
DELISTED
NYSE EURONEXT INC
NYX
| – | – |
-19,300
| Closed | -$810K |
|
|
DELL
544
DELISTED
DELL INC
DELL
| – | – |
-79,100
| Closed | -$1.09M |
|
|
SHPG
545
DELISTED
Shire pic
SHPG
| – | – |
-8,500
| Closed | -$1.02M |
|
Similar funds
AWM
SCM
ECM
TA
2L
CWM
AFM
CCM
Sentry Investment Management's Q4 2013 Portfolio in Review
As of Q4 2013, Sentry Investment Management held 545 positions worth $1.85B, up 9.5% from $1.69B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Sentry Investment Management's Q4 2013 filing shows 19 new, 207 increased, 207 reduced and 22 closed positions. Its largest new stake was Meta Platforms (Facebook): 98,400 shares worth $5.38M. The largest sale was Pfizer, an estimated $4.53M.
By sector, the portfolio is most concentrated in Financials at 9.1% of assets, up from 8.8% a quarter earlier, followed by Healthcare and Technology.
- Sentry Investment Management's largest Q4 2013 buy was Meta Platforms (Facebook): 98,400 shares worth $5.38M.
- Sentry Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2013, an estimated $8.76M increase.
- Sentry Investment Management's biggest Q4 2013 reduction was Pfizer, cutting an estimated $4.53M.
- Sentry Investment Management fully exited Olin in Q4 2013, selling an estimated $4.38M.
- Sentry Investment Management's ten largest holdings make up 44% of its $1.85B portfolio in Q4 2013.
- Sentry Investment Management opened 19 new positions and closed 22 in Q4 2013.
- Sentry Investment Management's portfolio value rose 9.5% quarter-over-quarter to $1.85B.
Based on Sentry Investment Management's 13F filing for Q4 2013, filed 10 Feb 2014.